A practical technique to avoid the hippocampus in prophylactic cranial irradiation for lung cancer

Radiotherapy and Oncology

Volumn 102, Issue 2, 2012, Pages 225-227

  Van Kesteren, Zdenko ^a   Belderbos, José ^a   Van Herk, Marcel ^a   Olszewska, Agnieszka ^a   Lamers, Emmy ^a   De Ruysscher, Dirk ^b   Damen, Eugène ^a   Van Vliet Vroegindeweij, Corine ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Hippocampus avoiding PCI; Neuro cognition; NSCLC; PCI

Indexed keywords

ARTICLE; BRAIN METASTASIS; CANCER PREVENTION; HIPPOCAMPUS; HUMAN; LUNG CANCER; PRIORITY JOURNAL; RADIATION DOSE; SKULL IRRADIATION; TREATMENT PLANNING;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; DOSE FRACTIONATION; FEMALE; HIPPOCAMPUS; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857627366     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.09.023     Document Type: Article

References (12)

1. A. Paumier, X. Cuenca, and C. Le Pechoux Prophylactic cranial irradiation in lung cancer Cancer Treat Rev 37 2011 261 265
2. E.M. Gore, K. Bae, S.J. Wong, A. Sun, J.A. Bonner, and S.E. Schild Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214 J Clin Oncol 29 2011 272 278
3. C. Pottgen, W. Eberhardt, A. Grannass, S. Korfee, G. Stuben, and H. Teschler Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial J Clin Oncol 25 2007 4987 4992
4. B.J. Slotman, M.E. Mauer, A. Bottomley, C. Faivre-Finn, G.W. Kramer, and E.M. Rankin Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups J Clin Oncol 27 2009 78 84
5. V. Gondi, W.A. Tome, and M.P. Mehta Why avoid the hippocampus? A comprehensive review Radiother Oncol 97 2010 370 376
6. V. Gondi, R. Tolakanahalli, M.P. Mehta, D. Tewatia, H. Rowley, and J.S. Kuo Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 78 2010 1244 1252
7. B.S. Chera, R.J. Amdur, P. Patel, and W.M. Mendenhall A radiation oncologist's guide to contouring the hippocampus Am J Clin Oncol 32 2009 20 22
8. A. Ghia, W.A. Tome, S. Thomas, G. Cannon, D. Khuntia, and J.S. Kuo Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation Int J Radiat Oncol Biol Phys 68 2007 971 977
9. V. Gondi, W.A. Tome, J. Marsh, A. Struck, A. Ghia, and J.V. Turian Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933 Radiother Oncol 95 2010 327 331
10. J.J. van der Sande, H. van Tinteren, D. Brandsma, G.J. Jobsis, and W. Boogerd Brain metastases in patients with pelvic or abdominal malignancy do not prevail in the posterior fossa: a retrospective study J Neurol 256 2009 1485 1487
11. Z. van Kesteren, A. Olszewska, J. Belderbos, and C. Vliet-Vroegindeweij The distribution of brain metastases in the perihippocampal region (Regarding Gondi et al., Radiother Oncol 2010;95:327-331) Radiother Oncol 98 2011 144
12. E.T. Bender, and W.A. Tome Distribution of brain metastases: implications for non-uniform dose prescriptions Br J Radiol 84 2011 649 658